Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2015
Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study
Babafemi O Taiwo, Ellen S Chan, Carl J Fichtenbaum, et al.
AIDS (London, England)
|
September 30, 2014
2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque
Markella V Zanni, Kathleen V Fitch, Meghan Feldpausch, et al.
The Journal of Infectious Diseases
|
June 29, 2012
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256
Timothy J Wilkin, Christina M Lalama, John McKinnon, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|
December 2, 2010
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participants
Benjamin J Grady, Eric S Torstenson, Paul J McLaren, et al.
Open Forum Infectious Diseases
|
March 4, 2015
Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study
Timothy J Henrich, Paul J McLaren, Suhas S P Rao, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 13, 2025
The Effect of Low Dose Methotrexate on Arterial Inflammation in Persons Living with Human Immunodeficiency Virus. A double-blind randomized placebo-controlled pilot trial
Ahmed Tawakol, Heather Ribaudo, Ashley McKhann, et al.
HIV Clinical Trials
|
January 18, 2011
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen
Scott M Hammer, Heather Ribaudo, Roland Bassett, et al.
AIDS (London, England)
|
November 7, 2015
Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery
Anthony R Cillo, Benedict B Hilldorfer, Christina M Lalama, et al.
The Journal of Antimicrobial Chemotherapy
|
March 11, 2021
Impact of pre-existing drug resistance on risk of virological failure in South Africa
Jonathan Z Li, Natalia Stella, Manish C Choudhary, et al.
The Journal of Infectious Diseases
|
July 10, 2020
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus
Edgar T Overton, Amy Kantor, Kathleen V Fitch, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2015
Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study
Babafemi O Taiwo, Ellen S Chan, Carl J Fichtenbaum, et al.
AIDS (London, England)
|
September 30, 2014
2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque
Markella V Zanni, Kathleen V Fitch, Meghan Feldpausch, et al.
The Journal of Infectious Diseases
|
June 29, 2012
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256
Timothy J Wilkin, Christina M Lalama, John McKinnon, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|
December 2, 2010
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participants
Benjamin J Grady, Eric S Torstenson, Paul J McLaren, et al.
Open Forum Infectious Diseases
|
March 4, 2015
Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study
Timothy J Henrich, Paul J McLaren, Suhas S P Rao, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 13, 2025
The Effect of Low Dose Methotrexate on Arterial Inflammation in Persons Living with Human Immunodeficiency Virus. A double-blind randomized placebo-controlled pilot trial
Ahmed Tawakol, Heather Ribaudo, Ashley McKhann, et al.
HIV Clinical Trials
|
January 18, 2011
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen
Scott M Hammer, Heather Ribaudo, Roland Bassett, et al.
AIDS (London, England)
|
November 7, 2015
Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery
Anthony R Cillo, Benedict B Hilldorfer, Christina M Lalama, et al.
The Journal of Antimicrobial Chemotherapy
|
March 11, 2021
Impact of pre-existing drug resistance on risk of virological failure in South Africa
Jonathan Z Li, Natalia Stella, Manish C Choudhary, et al.
The Journal of Infectious Diseases
|
July 10, 2020
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus
Edgar T Overton, Amy Kantor, Kathleen V Fitch, et al.
Page
of 5